NASDAQ · Biotechnology
Precision BioSciences Inc (DTIL)
$7.40
+7.09%
45
In band
Moving averages
SMA 200$6.75+9.63%
Company profile
Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. The company is headquartered in Durham, North Carolina.
SectorHealthcare
IndustryBiotechnology
Market cap$288.76M
P/E ratio31.52
EPS$0.24
Beta1.353
Dividend yield0.00%
52-week high$11.29
52-week low$3.53
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
ALLO
Allogene Therapeutics Inc
RSI 19
OCGN
Ocugen Inc
RSI 39
ARCT
Arcturus Therapeutics Holdings Inc
RSI 36
AGEN
Agenus Inc
RSI 44
EDIT
Editas Medicine Inc
RSI 30
ALT
Altimmune Inc
RSI 23
RSI alerts for DTIL
An email when DTIL closes below RSI 30 or above 70. Nothing else.
Data last updated 15 November 2026 at 12:42 AM EST